Risto Ala‐aho

3.1k total citations · 1 hit paper
27 papers, 2.6k citations indexed

About

Risto Ala‐aho is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Risto Ala‐aho has authored 27 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 13 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Risto Ala‐aho's work include Protease and Inhibitor Mechanisms (14 papers), Peptidase Inhibition and Analysis (9 papers) and TGF-β signaling in diseases (5 papers). Risto Ala‐aho is often cited by papers focused on Protease and Inhibitor Mechanisms (14 papers), Peptidase Inhibition and Analysis (9 papers) and TGF-β signaling in diseases (5 papers). Risto Ala‐aho collaborates with scholars based in Finland, United Kingdom and United States. Risto Ala‐aho's co-authors include Veli‐Matti Kähäri, Reidar Grénman, Pia Vihinen, Juha Peltonen, Markku Kallajoki, Nina Johansson, Ulpu Saarialho‐Kere, Melissa R. Junttila, Jukka Westermarck and Norbert E. Fusenig and has published in prestigious journals such as Cell, PLoS ONE and Oncogene.

In The Last Decade

Risto Ala‐aho

27 papers receiving 2.5k citations

Hit Papers

CIP2A Inhibits PP2A in Human Malignancies 2007 2026 2013 2019 2007 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CIP2A Inhibits PP2A in Human Malignancies
    2007 533 citations Melissa R. Junttila, Pietri Puustinen et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Risto Ala‐aho Finland 23 1.3k 977 942 298 264 27 2.6k
Isabelle Stoll France 23 1.5k 1.2× 1.3k 1.4× 1.1k 1.1× 270 0.9× 401 1.5× 32 2.8k
Hervé Emonard France 36 1000 0.8× 1.4k 1.4× 827 0.9× 400 1.3× 570 2.2× 81 3.2k
María Jiménez Spain 20 903 0.7× 667 0.7× 529 0.6× 338 1.1× 140 0.5× 29 1.9k
William T. Roswit United States 22 680 0.5× 610 0.6× 651 0.7× 562 1.9× 338 1.3× 25 2.2k
Michael D. Oberst Germany 29 1.1k 0.8× 380 0.4× 473 0.5× 296 1.0× 283 1.1× 77 2.7k
Ulrike Benbow United States 18 839 0.7× 1.0k 1.0× 599 0.6× 218 0.7× 342 1.3× 25 1.9k
Vishnu C. Ramani United States 23 1.5k 1.2× 850 0.9× 868 0.9× 172 0.6× 204 0.8× 31 2.6k
Khalid Bajou Belgium 25 1.4k 1.1× 1.6k 1.7× 627 0.7× 268 0.9× 581 2.2× 42 3.0k
Tetsuro Ikebe Japan 28 1.2k 1.0× 680 0.7× 1.0k 1.1× 251 0.8× 160 0.6× 81 2.5k
Daisuke Uchida Japan 25 1.2k 0.9× 676 0.7× 1.2k 1.2× 741 2.5× 145 0.5× 84 2.7k

Countries citing papers authored by Risto Ala‐aho

Since Specialization
Citations

This map shows the geographic impact of Risto Ala‐aho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risto Ala‐aho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risto Ala‐aho more than expected).

Fields of papers citing papers by Risto Ala‐aho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Risto Ala‐aho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risto Ala‐aho. The network helps show where Risto Ala‐aho may publish in the future.

Co-authorship network of co-authors of Risto Ala‐aho

This figure shows the co-authorship network connecting the top 25 collaborators of Risto Ala‐aho. A scholar is included among the top collaborators of Risto Ala‐aho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Risto Ala‐aho. Risto Ala‐aho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Farshchian, Mehdi, Liisa Nissinen, Elina Siljamäki, et al.. (2015). EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 135(7). 1882–1892. 45 indexed citations
2.
Riihilä, Pilvi, Liisa Nissinen, Mehdi Farshchian, et al.. (2014). Complement Factor I Promotes Progression of Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 135(2). 579–588. 65 indexed citations
3.
Riihilä, Pilvi, Liisa Nissinen, Risto Ala‐aho, et al.. (2013). Complement Factor H: A Biomarker for Progression of Cutaneous Squamous Cell Carcinoma. Journal of Investigative Dermatology. 134(2). 498–506. 75 indexed citations
4.
Toriseva, Mervi, Risto Ala‐aho, Sirkku Peltonen, et al.. (2012). Keratinocyte Growth Factor Induces Gene Expression Signature Associated with Suppression of Malignant Phenotype of Cutaneous Squamous Carcinoma Cells. PLoS ONE. 7(3). e33041–e33041. 22 indexed citations
5.
Endo, Hitoshi, Maki Niioka, Yoshihiko Sugioka, et al.. (2011). Matrix Metalloproteinase-13 Promotes Recovery from Experimental Liver Cirrhosis in Rats. Pathobiology. 78(5). 239–252. 55 indexed citations
6.
Farshchian, Mehdi, Atte Kivisaari, Risto Ala‐aho, et al.. (2011). Serpin Peptidase Inhibitor Clade A Member 1 (SerpinA1) Is a Novel Biomarker for Progression of Cutaneous Squamous Cell Carcinoma. American Journal Of Pathology. 179(3). 1110–1119. 72 indexed citations
7.
Kivisaari, Atte, Markku Kallajoki, Risto Ala‐aho, et al.. (2010). Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma. British Journal of Dermatology. 163(4). 726–735. 59 indexed citations
8.
Suomela, Sari, Outi Elomaa, Tiina Skoog, et al.. (2009). CCHCR1 Is Up-Regulated in Skin Cancer and Associated with EGFR Expression. PLoS ONE. 4(6). e6030–e6030. 29 indexed citations
9.
Vihinen, Pia, Risto Ala‐aho, & Veli‐Matti Kähäri. (2008). Diagnostic and prognostic role of matrix metalloproteases in cancer. Expert Opinion on Medical Diagnostics. 2(9). 1025–1039. 3 indexed citations
10.
Junttila, Melissa R., Pietri Puustinen, Minna Niemelä, et al.. (2007). CIP2A Inhibits PP2A in Human Malignancies. Cell. 130(1). 51–62. 533 indexed citations breakdown →
11.
Toriseva, Mervi, Risto Ala‐aho, Jarkko Karvinen, et al.. (2006). Collagenase-3 (MMP-13) Enhances Remodeling of Three-Dimensional Collagen and Promotes Survival of Human Skin Fibroblasts. Journal of Investigative Dermatology. 127(1). 49–59. 52 indexed citations
12.
Vihinen, Pia, Risto Ala‐aho, & Veli‐Matti Kähäri. (2005). Matrix Metalloproteinases as Therapeutic Targets in Cancer. Current Cancer Drug Targets. 5(3). 203–220. 230 indexed citations
13.
Ala‐aho, Risto, Reidar Grénman, Prem Seth, & Veli‐Matti Kähäri. (2002). Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Oncogene. 21(8). 1187–1195. 59 indexed citations
14.
Kerkelä, Erja, Risto Ala‐aho, Pekka Klemi, et al.. (2002). Metalloelastase (MMP‐12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. The Journal of Pathology. 198(2). 258–269. 84 indexed citations
15.
Ala‐aho, Risto, Reidar Grénman, Prem Seth, & Veli‐Matti Kähäri. (2002). Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Oncogene. 21(8). 1187–1195. 3 indexed citations
16.
Ahonen, Matti, Risto Ala‐aho, Andrew H. Baker, et al.. (2002). Antitumor Activity and Bystander Effect of Adenovirally Delivered Tissue Inhibitor of Metalloproteinases-3. Molecular Therapy. 5(6). 705–715. 65 indexed citations
17.
Kerkelä, Erja, Risto Ala‐aho, Leila Jeskanen, et al.. (2001). Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. British Journal of Cancer. 84(5). 659–669. 75 indexed citations
18.
Ala‐aho, Risto, Nina Johansson, Andrew H. Baker, & Veli‐Matti Kähäri. (2001). Expression of collagenase‐3 (MMP‐13) enhances invasion of human fibrosarcoma HT‐1080 cells. International Journal of Cancer. 97(3). 283–289. 45 indexed citations
19.
Kerkelä, Erja, Risto Ala‐aho, Leila Jeskanen, et al.. (2000). Expression of Human Macrophage Metalloelastase (MMP-12) by Tumor Cells in Skin Cancer. Journal of Investigative Dermatology. 114(6). 1113–1119. 82 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Stoll Breakdown of academic impact, for papers by Hervé Emonard Breakdown of academic impact, for papers by María Jiménez Breakdown of academic impact, for papers by William T. Roswit Breakdown of academic impact, for papers by Michael D. Oberst Breakdown of academic impact, for papers by Ulrike Benbow Breakdown of academic impact, for papers by Vishnu C. Ramani Breakdown of academic impact, for papers by Khalid Bajou Breakdown of academic impact, for papers by Tetsuro Ikebe Breakdown of academic impact, for papers by Daisuke Uchida
Rankless by CCL
2026